1. 28PSimultaneous unbiased and absolute quantification of a 500 protein panel in pancreatic cancer plasma using HRM mass spectrometry. (27th February 2019) Authors: Yu, H; Vowinckel, J; Escher, C; Heinzmann, D; Dupuis, N Journal: Annals of oncology Issue: Volume 30(2019)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 323PSubcutaneous trastuzumab (H SC) with intravenous pertuzumab (P IV) and docetaxel (D IV) in HER2-positive advanced breast cancer (BC): MetaPHER second interim analysis. (23rd October 2018) Authors: Kümmel, S; Tondini, C A; Abraham, J; Nowecki, Z I; Itrych, B; Hitre, E; Karaszewska, B; Juarez, A; Morales-Vásquez, F; Pérez García, J M; Cardona-Huerta, S; Heinzmann, D; He, J; Duc, A N; Crepelle-Fléchais, A; Martín, M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A novel local impedance algorithm and contact force sensing to guide high power short duration radiofrequency ablation is efficient and safe for circumferential pulmonary vein isolation. (24th May 2021) Authors: Schreieck, J; Heinzmann, D; Scheckenbach, C; Gawaz, M; Duckheim, M Journal: Europace Issue: Volume 23:Supplement 3(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Contact force-controlled high power short duration radiofrequency ablation enables efficient creation of roof line and anterior mitral line in course of low voltage areas. (19th May 2022) Authors: Schreieck, J; Seizer, P; Duckheim, M; Scheckenbach, C; Gawaz, M; Heinzmann, D Journal: Europace Issue: Volume 24:Supplement 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗